Recruiting OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. NCT04493632 Conditions Digestive System Disease, Digestive System Diseases, Digestive System Neoplasm, +13 more Locations Complejo Hospitalario Universitario Insular Materno-Infantil — Las Palmas de Gran Canaria, Spain Hospital Universitario Ramón y Cajal — Madrid, Spain Hospital Universitario de Fuenlabrada — Madrid, Spain Hospital Universitario Doce De Octobre — Madrid, Spain View more locations Show fewer locations Loading locations... View Trial Details
Completed Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors NCT03037385 Conditions Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more Locations Mayo Clinic Hospital — Phoenix, Arizona, United States UC Irvine Medical Center — Orange, California, United States University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States Georgetown University Medical Center — Washington D.C., District of Columbia, United States View all 71 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer NCT03562897 Conditions Adnexal Diseases, Carcinoma, Endocrine Gland Neoplasm, +23 more Locations National Institute of Oncology and Radiobiology (INOR) — Havana, Cuba View Trial Details
Completed Assessing the Patient Experience in Cancer Care NCT01621295 Conditions Brain Diseases, Brain Neoplasm, Brain Neoplasms, +44 more Locations Los Angeles County Hospital — Los Angeles, California, United States University of Southern California - Norris — Los Angeles, California, United States Mayo Clinic — Rochester, Minnesota, United States View Trial Details
